Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI143764.
Many solid cancers metastasize to the bone and bone marrow (BM). This process may occur even before the diagnosis of primary tumors, as evidenced by the discovery of disseminated tumor cells (DTCs) in patients without occult malignancies. The cellular fates and metastatic progression of DTCs are determined by complicated interactions between cancer cells and BM niches. Not surprisingly, these niches also play important roles in normal biology, including homeostasis and turnover of skeletal and hematopoiesis systems. In this Review, we summarize recent findings on functions of BM niches in bone metastasis (BoMet), particularly during the early stage of colonization. In light of the rich knowledge of hematopoiesis and osteogenesis, we highlight how DTCs may progress into overt BoMet by taking advantage of niche cells and their activities in tissue turnover, especially those related to immunomodulation and bone repair.
许多实体瘤转移到骨骼和骨髓(BM)。即使在原发性肿瘤诊断之前,也可能发生这种情况,因为在没有隐匿性恶性肿瘤的患者中发现了播散性肿瘤细胞(DTCs)。DTCs 的细胞命运和转移进展是由癌细胞和 BM 龛之间复杂的相互作用决定的。毫不奇怪,这些龛位在正常生物学中也发挥着重要作用,包括骨骼和造血系统的稳态和更新。在这篇综述中,我们总结了 BM 龛位在骨转移(BoMet)中的功能的最新发现,特别是在定植的早期阶段。鉴于造血和成骨方面的丰富知识,我们强调了 DTCs 如何通过利用龛位细胞及其在组织更新中的活性(特别是与免疫调节和骨修复相关的活性)进展为明显的 BoMet。